ResMed Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
ResMed Inc. (RSMDF) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $38.98 million as of 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2026-08-13
- 2026-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $38.98M.
- 2025-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $37.19M.
- 2024-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $35.34M.
- 2023-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $34.31M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits |
|---|---|
| 2026-06-30 | $38.98M 10-K · filed 2026-08-13 |
| 2025-06-30 | $37.19M 10-K · filed 2026-08-13 |
| 2024-06-30 | $35.34M 10-K · filed 2025-08-08 |
| 2023-06-30 | $34.31M 10-K · filed 2024-08-09 |
| 2022-06-30 | $28.56M 10-K · filed 2023-08-11 |
| 2021-06-30 | $30.08M 10-K · filed 2022-08-12 |
| 2020-06-30 | $21.27M 10-K · filed 2021-08-17 |
| 2019-06-30 | $18.10M 10-K · filed 2020-08-13 |
| 2018-06-30 | $16.18M 10-K · filed 2019-08-08 |
| 2017-06-30 | $19.27M 10-K · filed 2018-08-17 |
| 2016-06-30 | $15.51M 10-K · filed 2017-08-04 |
| 2015-06-30 | $11.66M 10-K · filed 2016-08-05 |
| 2014-06-30 | $11.61M 10-K · filed 2015-08-07 |
| 2013-06-30 | $10.60M 10-K · filed 2014-08-08 |
| 2012-06-30 | $10.75M 10-K · filed 2013-08-13 |
| 2011-06-30 | $8.01M 10-K · filed 2012-08-14 |
| 2010-06-30 | $5.47M 10-K · filed 2011-08-17 |